oral semaglutide cardiovascular outcomes soul trial results 2024 2025 Reduces CV Events in T2DM β (NEJM, Mar 2025) Relevant for: cardiology, diabetology, nephrology, internal medicine π§ͺ T2DM + ASCVD/CKD π Oral semaglutide 14 mg vs placebo π Semaglutide cardiovascular outcomes align more
Description
The compounded formulation contains identical active pharmaceutical ingredients and maintains the same effectiveness profile as FDA-approved versions, with pricing starting at $149 monthly
doi: 10.1007/s10557-005-6892-4 84 QaatyNWangYWangAMaoSVincentMHusainMet al
Many insurance plans cover it for patients with obesity and related health conditions, while others consider it a cosmetic treatment
The medication he was using required twice-daily injections
The relationship between high-fat foods and semaglutide-related gastrointestinal symptoms deserves particular attention due to the frequency and severity of reactions patients experience
If you are using both, increase electrolyte supplementation accordingly and monitor for signs of excessive fluid loss
